201 related articles for article (PubMed ID: 26135399)
1. Neuroimaging Analysis of the Dopamine Basis for Apathetic Behaviors in an MPTP-Lesioned Primate Model.
Tian L; Xia Y; Flores HP; Campbell MC; Moerlein SM; Perlmutter JS
PLoS One; 2015; 10(7):e0132064. PubMed ID: 26135399
[TBL] [Abstract][Full Text] [Related]
2. Dopamine pathway loss in nucleus accumbens and ventral tegmental area predicts apathetic behavior in MPTP-lesioned monkeys.
Brown CA; Campbell MC; Karimi M; Tabbal SD; Loftin SK; Tian LL; Moerlein SM; Perlmutter JS
Exp Neurol; 2012 Jul; 236(1):190-7. PubMed ID: 22579525
[TBL] [Abstract][Full Text] [Related]
3. Validation of nigrostriatal positron emission tomography measures: critical limits.
Karimi M; Tian L; Brown CA; Flores HP; Loftin SK; Videen TO; Moerlein SM; Perlmutter JS
Ann Neurol; 2013 Mar; 73(3):390-6. PubMed ID: 23423933
[TBL] [Abstract][Full Text] [Related]
4. Levodopa induces long-lasting modification in the functional activity of the nigrostriatal pathway.
Riverol M; Ordóñez C; Collantes M; DiCaudo C; Peñuelas I; Arbizu J; Marcilla I; Luquin MR
Neurobiol Dis; 2014 Feb; 62():250-9. PubMed ID: 24076099
[TBL] [Abstract][Full Text] [Related]
5. Mapping dopamine function in primates using pharmacologic magnetic resonance imaging.
Jenkins BG; Sanchez-Pernaute R; Brownell AL; Chen YC; Isacson O
J Neurosci; 2004 Oct; 24(43):9553-60. PubMed ID: 15509742
[TBL] [Abstract][Full Text] [Related]
6. Carboxyfullerene neuroprotection postinjury in Parkinsonian nonhuman primates.
Dugan LL; Tian L; Quick KL; Hardt JI; Karimi M; Brown C; Loftin S; Flores H; Moerlein SM; Polich J; Tabbal SD; Mink JW; Perlmutter JS
Ann Neurol; 2014 Sep; 76(3):393-402. PubMed ID: 25043598
[TBL] [Abstract][Full Text] [Related]
7. Imaging Dopamine and Serotonin Systems on MPTP Monkeys: A Longitudinal PET Investigation of Compensatory Mechanisms.
Ballanger B; Beaudoin-Gobert M; Neumane S; Epinat J; Metereau E; Duperrier S; Broussolle E; Thobois S; Bonnefoi F; Tourvielle C; Lavenne F; Costes N; Lebars D; Zimmer L; Sgambato-Faure V; Tremblay L
J Neurosci; 2016 Feb; 36(5):1577-89. PubMed ID: 26843639
[TBL] [Abstract][Full Text] [Related]
8. Cerebral metabolic pattern associated with progressive parkinsonism in non-human primates reveals early cortical hypometabolism.
Molinet-Dronda F; Blesa J; Del Rey NL; Juri C; Collantes M; Pineda-Pardo JA; Trigo-Damas I; Iglesias E; Hernández LF; Rodríguez-Rojas R; Gago B; Ecay M; Prieto E; García-Cabezas MÁ; Cavada C; Rodríguez-Oroz MC; Peñuelas I; Obeso JA
Neurobiol Dis; 2022 Jun; 167():105669. PubMed ID: 35219857
[TBL] [Abstract][Full Text] [Related]
9. Validation of midbrain positron emission tomography measures for nigrostriatal neurons in macaques.
Brown CA; Karimi MK; Tian L; Flores H; Su Y; Tabbal SD; Loftin SK; Moerlein SM; Perlmutter JS
Ann Neurol; 2013 Oct; 74(4):602-10. PubMed ID: 23686841
[TBL] [Abstract][Full Text] [Related]
10. Effect of MPTP on Serotonergic Neuronal Systems and Mitochondrial Complex I Activity in the Living Brain: A PET Study on Conscious Rhesus Monkeys.
Kanazawa M; Ohba H; Nishiyama S; Kakiuchi T; Tsukada H
J Nucl Med; 2017 Jul; 58(7):1111-1116. PubMed ID: 28280215
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of 6-11C-Methyl-m-Tyrosine as a PET Probe for Presynaptic Dopaminergic Activity: A Comparison PET Study with β-11C-l-DOPA and 18F-FDOPA in Parkinson Disease Monkeys.
Kanazawa M; Ohba H; Harada N; Kakiuchi T; Muramatsu S; Tsukada H
J Nucl Med; 2016 Feb; 57(2):303-8. PubMed ID: 26564319
[TBL] [Abstract][Full Text] [Related]
12. Effect of age on markers for monoaminergic neurons of normal and MPTP-lesioned rhesus monkeys: a multi-tracer PET study.
Doudet DJ; Rosa-Neto P; Munk OL; Ruth TJ; Jivan S; Cumming P
Neuroimage; 2006 Mar; 30(1):26-35. PubMed ID: 16378735
[TBL] [Abstract][Full Text] [Related]
13. The nigrostriatal system in the presymptomatic and symptomatic stages in the MPTP monkey model: a PET, histological and biochemical study.
Blesa J; Pifl C; Sánchez-González MA; Juri C; García-Cabezas MA; Adánez R; Iglesias E; Collantes M; Peñuelas I; Sánchez-Hernández JJ; Rodríguez-Oroz MC; Avendaño C; Hornykiewicz O; Cavada C; Obeso JA
Neurobiol Dis; 2012 Oct; 48(1):79-91. PubMed ID: 22677034
[TBL] [Abstract][Full Text] [Related]
14. The prominent role of serotonergic degeneration in apathy, anxiety and depression in de novo Parkinson's disease.
Maillet A; Krack P; Lhommée E; Météreau E; Klinger H; Favre E; Le Bars D; Schmitt E; Bichon A; Pelissier P; Fraix V; Castrioto A; Sgambato-Faure V; Broussolle E; Tremblay L; Thobois S
Brain; 2016 Sep; 139(Pt 9):2486-502. PubMed ID: 27538418
[TBL] [Abstract][Full Text] [Related]
15. Modification of the number and phenotype of striatal dopaminergic cells by carotid body graft.
San Sebastián W; Guillén J; Manrique M; Belzunegui S; Ciordia E; Izal-Azcárate A; Garrido-Gil P; Vázquez-Claverie M; Luquin MR
Brain; 2007 May; 130(Pt 5):1306-16. PubMed ID: 17439984
[TBL] [Abstract][Full Text] [Related]
16. Progression of dopaminergic depletion in a model of MPTP-induced Parkinsonism in non-human primates. An (18)F-DOPA and (11)C-DTBZ PET study.
Blesa J; Juri C; Collantes M; Peñuelas I; Prieto E; Iglesias E; Martí-Climent J; Arbizu J; Zubieta JL; Rodríguez-Oroz MC; García-García D; Richter JA; Cavada C; Obeso JA
Neurobiol Dis; 2010 Jun; 38(3):456-63. PubMed ID: 20304066
[TBL] [Abstract][Full Text] [Related]
17. Overlesioned hemiparkinsonian non human primate model: correlation between clinical, neurochemical and histochemical changes.
Oiwa Y; Eberling JL; Nagy D; Pivirotto P; Emborg ME; Bankiewicz KS
Front Biosci; 2003 Sep; 8():a155-66. PubMed ID: 12957824
[TBL] [Abstract][Full Text] [Related]
18. Gait disorders in parkinsonian monkeys with pedunculopontine nucleus lesions: a tale of two systems.
Grabli D; Karachi C; Folgoas E; Monfort M; Tande D; Clark S; Civelli O; Hirsch EC; François C
J Neurosci; 2013 Jul; 33(29):11986-93. PubMed ID: 23864685
[TBL] [Abstract][Full Text] [Related]
19. Cell survival patterns in the pedunculopontine tegmental nucleus of methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys and 6OHDA-lesioned rats: evidence for differences to idiopathic Parkinson disease patients?
Heise CE; Teo ZC; Wallace BA; Ashkan K; Benabid AL; Mitrofanis J
Anat Embryol (Berl); 2005 Nov; 210(4):287-302. PubMed ID: 16237536
[TBL] [Abstract][Full Text] [Related]
20. GM-1 ganglioside promotes the recovery of surviving midbrain dopaminergic neurons in MPTP-treated monkeys.
Herrero MT; Perez-Otaño I; Oset C; Kastner A; Hirsch EC; Agid Y; Luquin MR; Obeso JA; Del Rio J
Neuroscience; 1993 Oct; 56(4):965-72. PubMed ID: 7904332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
